|
Lymphoid Neoplasia
Citations 201-210 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- Wing-yan Au, Dennis D. Weisenburger, Tanin Intragumtornchai, Shigeo Nakamura, Won-Seog Kim, Ivy Sng, Julie Vose, James O. Armitage, Raymond Liang, and for the International Peripheral T-Cell Lymphoma Project
Blood 2009; 113: 3931-3937.
[Abstract]
[Full text]
[PDF]
The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group
- Thomas Burmeister, Claus Meyer, Stefan Schwartz, Julia Hofmann, Mara Molkentin, Eric Kowarz, Björn Schneider, Thorsten Raff, Richard Reinhardt, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, and Rolf Marschalek
Blood 2009; 113: 4011-4015.
[Abstract]
[Full text]
[PDF]
Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability
- Cynthia A. Pise-Masison, Michael Radonovich, Kathleen Dohoney, John C. Morris, Deirdre O'Mahony, Min-Jung Lee, Jane Trepel, Thomas A. Waldmann, John E. Janik, and John N. Brady
Blood 2009; 113: 4016-4026.
[Abstract]
[Full text]
[PDF]
Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF- B with antimyeloma activity in vitro and in vivo
- Rodger E. Tiedemann, Jessica Schmidt, Jonathan J. Keats, Chang-Xin Shi, Yuan Xiao Zhu, Stephen E. Palmer, Xinliang Mao, Aaron D. Schimmer, and A. Keith Stewart
Blood 2009; 113: 4027-4037.
[Abstract]
[Full text]
[PDF]
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism
- Jianguang Chen, Warren Fiskus, Kelly Eaton, Pravina Fernandez, Yongchao Wang, Rekha Rao, Pearl Lee, Rajeshree Joshi, Yonghua Yang, Ravindra Kolhe, Ramesh Balusu, Prasanthi Chappa, Kavita Natarajan, Anand Jillella, Peter Atadja, and Kapil N. Bhalla
Blood 2009; 113: 4038-4048.
[Abstract]
[Full text]
[PDF]
Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia
- Tamara Riedt, Martin Ebinger, Helmut R. Salih, Jürgen Tomiuk, Rupert Handgretinger, Lothar Kanz, Frank Grünebach, and Claudia Lengerke
Blood 2009; 113: 4049-4051.
[Abstract]
[Full text]
[PDF]
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
- Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, and Eva Kimby
Blood 2009; 113: 3673-3678.
[Abstract]
[Full text]
[PDF]
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma
- Marie L. De Bruin, Jacobus A. Burgers, Paul Baas, Mars B. van 't Veer, Evert M. Noordijk, Marieke W. J. Louwman, Josée M. Zijlstra, Hendrik van den Berg, Berthe M. P. Aleman, and Flora E. van Leeuwen
Blood 2009; 113: 3679-3681.
[Abstract]
[Full text]
[PDF]
In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein
- Risaku Fukumoto, Vibeke Andresen, Izabela Bialuk, Valentina Cecchinato, Jean-Claude Walser, Valerio W. Valeri, Julie M. Nauroth, Antoine Gessain, Christophe Nicot, and Genoveffa Franchini
Blood 2009; 113: 3726-3734.
[Abstract]
[Full text]
[PDF]
The impact of Fc engineering on an anti-CD19 antibody: increased Fc receptor affinity enhances B-cell clearing in nonhuman primates
- Jonathan Zalevsky, Irene W. L. Leung, Sher Karki, Seung Y. Chu, Eugene A. Zhukovsky, John R. Desjarlais, David F. Carmichael, and Chris E. Lawrence
Blood 2009; 113: 3735-3743.
[Abstract]
[Full text]
[PDF]
|
|
